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Meniscal injuries in the vascularized peripheral part of the meniscus have a better healing potential than tears in the central
avascularzonebecausemeniscalhealingprincipallydependsonitsvascularsupply.Severalbiologicalstrategieshavebeenproposed
to enhance healing of the avascular area of the meniscus: abrasion therapy, ﬁbrin clot, organ culture, cell therapy, and applications
of growth factors. However, data are too heterogeneous to achieve deﬁnitive conclusions on the use of these techniques for
routine management of meniscal lesions. Although most preclinical and clinical studies are very promising, they are still at an
experimental stage. More prospective randomised controlled trials are needed to compare the diﬀerent techniques for clinical
results, applicability, and cost-eﬀectiveness.
1.Introduction
The menisci of the knee are two semilunar ﬁbrocartilaginous
structures sitting between the joint surfaces of femoral
condyles and the tibial plateau. Meniscal injuries are a
common and important source of knee dysfunction. Repair
should be considered depending on the type and location
of the meniscal tear [1–3], as meniscal healing principally
depends on the vascular supply of the zone that has been
injured [4]. A rich network of arborizing vessels within the
peripheralcapsularandsynovialattachmentssuppliesvascu-
larizationtothemenisci.Thisperimeniscalnetworkprovides
radial branches to the meniscus. The outer third of the
meniscus is vascularised, showing a good healing capacity.
Given its abundant vascularization, this zone is also called
“red-red zone.” The remaining two-thirds of the meniscus,
respectively called “red-white zone” and “white-white zone,”
have a scanty vascular supply and present a limited ability to
heal spontaneously [4–7].
A meniscal lesion followed by disruption of the struc-
ture in the avascular zone impairs load distribution and
initiates erosion of the adjacent articular surfaces, causing
osteoarthritis (OA) [8–11]. The most common treatment for
lesions of the avascular part of the meniscus is arthroscopic
partialmeniscectomy,whichreducessymptomsbutsimilarly
predisposes patients to OA [12]. Studies have demonstrated
that healing of the knee is inversely related to the amount
of resected meniscal tissue [10, 11, 13, 14]. Meniscal repair
techniquesintheavascularzoneareincontinuousevolution.
This paper covers current knowledge on biological
strategies for the stimulation of meniscal healing after repair.
2. Abrasion Therapy
Rasping of the damaged meniscus in the vascularized par-
ameniscal synovium promotes an injury response and is
one of the most simple and eﬀective strategies to favour
healing [3]. A small incision is performed to produce a
vascular channel that redirects the blood ﬂow from the
vascular zone into the avascular one. Several studies showed
a signiﬁcant diﬀerence in healing between menisci treated2 Stem Cells International
with abrasion therapy and control groups [15, 16]. The
most common techniques of abrasion therapy are rasping
or trephination, in which radially oriented channels are
performed to encourage vascular and cellular migration
from the peripheral vascular portion to the tear site [17–19].
Rasping increases the production of interleukin-I-alpha (IL-
1-alpha), transforming-growth-factor-beta 1 (TGF-beta1),
platelet-derived growth factor (PDGF), and proliferating cell
nuclear antigen (PCNA). This protein network improves
vascular induction and meniscal healing [20]. Neverthe-
less, trephination and rasping procedures may damage the
normal meniscal structure by an additional full thickness-
transverse tear, resulting in poor meniscal function.
3. Fibrin Clot
Fibrin is a ﬁbrous protein produced in response to bleeding
that plays an important role in blood clotting. Fibrin clots
may be used topically or by injection as an haemostatic
agent, binding to several adhesive proteins of diﬀerent cells
[21–33]. The ﬁbrin clot technique acts as a chemotactic
and mitogenic stimulus for reparative cells because of the
presence of several growth factors [34–37]. The ﬁbrin clot
attaches to the exposed collagen caused by the tear and
induces proliferation of ﬁbrous connective tissue [38–44].
This stimulates the development of ﬁbrocartilaginous tissue.
The ﬁbrin clot technique can be used in combination with
abrasion therapy or with meniscal sutures [45–57]. Two
studies in animal models showed that organized ﬁbrous
connective tissue developed into cartilaginous tissue after a
period of 12–24 weeks [58, 59]. A potential disadvantage of
the ﬁbrin clot technique is the diﬃculty of keeping ﬁbrin
clots on the tear without immobilizing the operated leg [60].
4.OrganCulture
Organ culture is a useful model to assess the intrinsic
healing potential of the meniscus excluding the inﬂuence
of microvasculature and the synovium [61–63]. The eﬀects
of cultured meniscal explants in a rabbit model have been
reported [63]. After gross evaluation, each meniscal explant
underwent histological evaluation to study the relationship
between the graft and recipient tissue. Application of this
technique has demonstrated that meniscal tissue presents an
intrinsic healing ability, which is greater in the peripheral
zone of the meniscus than in the inner zone [63]. Regional
diﬀerences in healing potential and extrinsic factors, such
as blood supply, could explain good meniscal healing in the
peripheral zone.
5. Cell Therapy
Human menisci are populated by diﬀerent cell types, re-
sponding diﬀerently to various stimuli released from the
matrix [64, 65]. Diﬀerent cells have already been used in
studies on meniscal healing: mesenchymal stem cells (MSCs)
deriving from synovial or bone marrow, chondrocytes, and
ﬁbrochondrocytes. MSCs are pluripotent cells able to dif-
ferentiate into speciﬁc therapeutic cell types (developmental
plasticity) [66–68]. The eﬀects of bioactive molecules, which
are secreted by MSCs, determine a regenerative microenvi-
ronment that promotes healing of meniscal lesions [69, 70].
The combination of suturing and MSC treatment, combined
or not with ﬁbrin glue, seems to be the most eﬀective
treatment [71].
Zellner et al. [70] reported the eﬃcacy of mesenchymal
stem cells in the repair of meniscal defects in the avascular
zone. Nonprecultured mesenchymal stem cells in hya-lu-
ronan-collagen composite matrices stimulated the develop-
ment of completely integrated meniscus-like repair tissue in
defectsproducedintheavascularzoneofrabbitmenisci[70].
Further studies conﬁrm the production of abundant
extracellular matrix around the cells, restoring a meniscal-
like tissue in the avascular zone [70, 72–75]. These results are
supported by early studies which demonstrated the eﬃcacy
of the association between growth factors and mesenchymal
stem cells within scaﬀold implants to increase proteoglycans
and/or collagen synthesis [70, 76]. Articular autologous
and allogenic chondrocytes have also been used to induce
repair in the avascular part of the meniscus [77, 78].
Peretti et al. described a porcine chondrocyte model where
implantation of such cells was performed in the avascular
part of the meniscus using an allogenic scaﬀold seeded with
autologous chondrocytes. These chondrocytes were eﬀective
in promoting healing meniscal tears [77]. Fibrochondrocytes
showed potential for initiating a reparative response in
meniscal defects through the production of new extracellular
matrix (ECM) [79, 80]. When seeded into a porous collagen
scaﬀold, ﬁbrochondrocytes harvested from the inner avascu-
lar part of the meniscus produce more glycosaminoglycans
(GAGs) than ﬁbrochondrocytes from a peripheral ﬁbrous
location [81, 82]. Although these ﬁndings are encouraging,
the application of autologous ﬁbrochondrocytes in meniscal
tissue engineering is limited by the diﬃculty in harvesting a
suﬃcient number of cells [83–93].
6. Growth Factors
Growth factors act as signalling molecules on target cells to
stimulate the regeneration of damaged tissue [6]. Further-
more, they can induce the synthesis and inhibit degradation
of ECM by a mechanism of downregulation of proteases
[94]. Several studies in vitro and in vivo evaluated the eﬀects
of treatment with speciﬁc growth factors. Two categories
of growth factors in consideration of their biochemical
attributes are generally considered: anabolic and catabolic
growth factors.
6.1. Anabolic Growth Factors
6.1.1. Fibroblast Growth Factor (FGF). basic FGF was used to
stimulate type II collagen and aggrecan mRNA production
in cellular and tissue development [95, 96]. In an ovine
experimental model, meniscal ﬁbrochondrocytes responded
to bFGF by proliferating and producing new extracellularStem Cells International 3
matrix [79]. Another FGF type, FGF-2, stimulates prolif-
eration of the joint chondrocytes, mesenchymal stem cells,
osteoblasts, and adipocytes. Furthermore, it maintains the
ability of any cell types to diﬀerentiate [97, 98]. Moreover,
a hyperexpression of FGF-2 and alpha-smooth muscle actin
(alpha-SMA) through recombinant adeno-associated virus
(rAAV) enhanced cell proliferation and increased survival
rate compared with control groups. However, FGF did not
signiﬁcantly increase the synthesis of major extracellular
matrix components or DNA contents [99].
6.1.2. Transforming-Growth-Factor-Beta (TGF-Beta). TGF-
beta seems to have several regulatory activities, stimulating
collagen and proteoglycan production to increase the attach-
ment of the cells in repaired meniscal tissue. Nevertheless, it
has no eﬀect on cell proliferation [6, 100–103].
6.1.3. Bone Morphogenetic Proteins (BMPs). BMPs are a
group of growth factors belonging to the TGF-β superfamily
playing an important role during embryogenesis and tissue
repair in relation to their osteoinductive properties [104,
105]. BMP-2 acts as a stimulus in the diﬀerentiation of
mesenchymal cells. It also presents a migratory eﬀect in
endothelial cells or smooth muscle cells, but rarely in
chondrocytes [106]. BMP-7 regulates matrix homeostasis
and inhibits the processes of degradation. BMP-7 acts with
diﬀerent chondrogenic agents and is more eﬀective than
BMP-2 in chondrogenic diﬀerentiation of MSCs in promot-
ing meniscal healing [107].
6.1.4. Insulin-Like-Growth-Factor-I (IGF-I). This is consid-
ered the main anabolic growth factor for articular cartilage
[108, 109]. Unlike TGF-beta I, IGF-I increases cell prolifer-
ation signiﬁcantly but has no eﬀect on the attachment [95].
Therefore, a mixture of growth factors in association with
IGF-I could induce an extensive cellular response to mediate
avascular meniscal healing [100].
6.1.5. Vascular Endothelial Growth Factor (VEGF). The
induction of angiogenesis is important to stimulate healing
of meniscal tears [110–122]. Vascular endothelial growth
factor (VEGF) may promote better healing, stimulating an-
giogenesis to improve the healing capacities of meniscus
tissue. In adults, VEGF expression is downregulated by
endostatin, mostly in the avascular zone [123]. However, the
local application of VEGF did not show an improvement of
meniscal healing [124].
6.1.6. Platelet-Derived Growth Factor-AB (PDGF-AB).
PDGF-AB plays an important role in the angiogenesis and
cell development [125, 126]. The application of PDGF-AB
in the peripheral part of the menisci showed a better
healing response than the application in the central part
[127]. However, this anabolic growth factor increased both
cell proliferation and ECM formation in all zones of the
meniscus, including the avascular zone [128].
6.2. Catabolic Growth Factors
6.2.1. Endostatin. Endostatin is an antiangiogenic factor ex-
pressed by ﬁbrochondrocytes in the avascular zone of men-
isci. Endostatin concentrations were higher when ﬁbrochon-
drocytes were in coculture with MSCs, suggesting that men-
iscalcellgrowthis inhibited bytheproliferationofMSCs[7].
6.2.2. Interleukin-I (IL-I). This is a proinﬂammatory cytok-
ine that stimulates the development of a local inﬂammatory
reaction. Meniscal explants treated with IL-I have failed to
show any signs of regeneration [129]. These ﬁndings suggest
that relevant expression of IL-I in association with higher
levels of tumor-necrosis-factor-alpha (TNF-alpha) inhibit
meniscal repair [130].
7.PlateletRichPlasma
Platelet-rich plasma (PRP) is an autologous substance rich
in platelets that releases growth factors from both alpha
and dense granules [131–150]. These growth factors have
been associated with the initiation of a healing cascade
leading to cellular chemotaxis, angiogenesis, collagen matrix
synthesis, and cell proliferation [151]. Ishida et al. reported
the eﬀects of PRP on meniscal tissue regeneration, both
in vitro and in vivo, in a rabbit model. In the in vitro
study, monolayer meniscal cell cultures were prepared and
proliferative behaviour, extracellular matrix (ECM) synthe-
sis, and ﬁbrocartilage-related messenger ribonucleic acid
(mRNA) expressions were assessed in the presence of PRP.
PRP stimulated DNA synthesis, ECM synthesis, and mRNA
expression of biglycan and decorin [152–161]. In the in vivo
study, full-thickness defects were produced in the avascular
region of rabbit meniscus. Gelatin hydrogel (GH) was used
to deliver PRP into the defects. At histology 12 weeks after
surgery, signiﬁcantly better meniscal repair was evident in
animals that received PRP with GH than in the control
groups [162].
In contrast, Zellner et al. evaluated several cell and
biomaterial-based treatment options for repair of defects
in the avascular zone of rabbit menisci by producing
circular meniscal punch defects in the avascular zone
of rabbit menisci. The defects were left empty or ﬁlled
with hyaluronan-collagen composite matrices without cells
loaded with platelet-rich plasma, autologous bone marrow,
or autologous mesenchymal stem cells. Neither bone mar-
row nor platelet-rich plasma loaded in matrices induced
improvement in meniscal healing [70].
8. Discussion
In the last few decades, many studies on meniscal healing
have focused on methods to enhance the healing capacities
of the meniscus after repair [163–178]. Abrasion of the torn
meniscus and synovial tissue or the establishment of vascular
channels to redirect blood ﬂow into the avascular zone
seems to be the preferred treatment [3, 15, 16]. However,
the healing potential depends on the type and location of4 Stem Cells International
the tear and its distance from the peripheral vascularised
zone. The use of a ﬁbrin clot can also be an eﬀective
technique to support a reparative response in the avascular
zone of the meniscus [34, 35, 37]. Findings demonstrated
that the rasping technique is more eﬀective than ﬁbrin clot
application to improve meniscal healing [179]. Kobayashi
et al. reported healing rates in the peripheral zone of the
menisci in an on-organ culture model. Regional diﬀerences
in healing potential and extrinsic factors, such as a blood
supply, could explain the good meniscal healing potential in
the peripheral zone [63].
Cell-based therapy for meniscal tears has signiﬁcantly
contributed to an increasing number of patients treated with
repair techniques rather than meniscectomy. Diﬀerent cell
types have already been used in studies on meniscus healing:
MSCs, articular chondrocytes and autologous ﬁbrochondro-
cytes [70, 77, 81, 82] .P r o g e n i t o rc e l l ss u c ha sm e s e n c h y m a l
stem cells present the advantage of being easily expandable
without losing their diﬀerentiation potential into a variety
of mesenchymal tissues including bone, tendon, cartilage,
muscle, ligament, fat, and marrow stroma [64, 66, 68].
The application of MSCs and their stimulation with growth
factors in combination with a mechanically loadable scaﬀold
have been proposed as the focus of future studies [135, 148].
Several studies reported the eﬃcacy of mesenchymal
stem cells in the repair of meniscal defects in the avascular
zone, with production of abundant extracellular matrix
around the cells and restoration of a meniscal-like tissue
[70, 72–75]. Early studies demonstrated the eﬃcacy of the
association between growth factors and mesenchymal stem
cellswithinscaﬀoldimplantstoincreaseproteoglycanand/or
collagensynthesis[180–196].Therefore,thehealingresponse
of mesenchymal stem cells seems to produce additional
repairqualitiesbesidesthedeliveryofgrowthfactors[70,76].
Many studies have shown the importance of growth
factors in the treatment of meniscal tears of the avascular
portion,butthereisaverycomplexinterplayamongavariety
of factors that inﬂuences healing processes. Growth factors
that promote cell diﬀerentiation and chondrocytic prolif-
eration include both anabolic growth factors (TGF-beta I,
BMPs, IGF-I, FGF, VEGF, and PDGF-AB) and catabolic
growth factors (endostatin, IL-1, and TNF-alpha). Anabolic
growth factors could be of additional value in improving
the healing of meniscal lesions [6, 79, 95–109, 123–128].
However, the application of growth factors remains very
limited in clinical settings [6, 95]. Future research should
focus on the use of tissue-engineered constructs in associa-
tion with diﬀerent growth factors [197–203]. A preparation
rich in growth factors could produce better results than the
use of isolated growth factors. Only a few studies to date
have evaluated the eﬀectiveness of a preparation of platelet-
rich plasma (PRP), but there is some evidence that PRP can
improve healing of the menisci [127, 128]. The release of
growth factors from platelets has been associated with the
initiation of a healing cascade leading to cellular chemotaxis,
angiogenesis,collagenmatrixsynthesis,andcellproliferation
[151, 162]. In contrast, a study in an animal model reported
that application of PRP did not produce improvements in
meniscal healing [70].
9. Conclusion
Patients with meniscal tears report pain and functional
limitation of the knee joint. Partial meniscectomy is the most
common treatment option, but it represents a predisposing
factor for osteoarthritis [12]. To date only limited scientiﬁ-
cally proven management modalities are available. A better
understanding of meniscal healing mechanisms will allow
speciﬁc treatment strategies to be developed. Although most
preclinical and clinical studies are very promising, they are
still at an experimental stage. Further prospective trials are
necessary to compare the diﬀerent techniques for eﬃcacy,
applicability, and cost-eﬀectiveness in the management of
lesions of the avascular region of the meniscus.
References
[1] E. Rath and J. C. Richmond, “The menisci: basic science and
advancesintreatment,”BritishJournalofSportsMedicine,vol.
34, no. 4, pp. 252–257, 2000.
[2] K. Messner and J. Gao, “The menisci of the knee joint.
Anatomicalandfunctionalcharacteristics,andarationalefor
clinical treatment,” Journal of Anatomy, vol. 193, no. 2, pp.
161–178, 1998.
[3] S. P. Arnoczky and R. F. Warren, “The microvasculature of
the meniscus and its response to injury. An experimental
study in the dog,” American Journal of Sports Medicine, vol.
11, no. 3, pp. 131–141, 1983.
[4] S. P. Arnoczky and R. F. Warren, “microvasculature of the
human meniscus,” American Journal of Sports Medicine, vol.
10, no. 2, pp. 90–95, 1982.
[5] F. N. Ghadially, J. M. A. Lalonde, and J. H. Wedge,
“Ultrastructure of normal and torn menisci of the human
knee joint,” Journal of Anatomy, vol. 136, no. 4, pp. 773–791,
1983.
[6] F. Forriol, “Growth factors in cartilage and meniscus repair,”
Injury, vol. 40, supplement 3, pp. S12–S16, 2009.
[7] M. Hoberg, E. L. Schmidt, M. Tuerk, V. Stark, W. K. Aicher,
and M. Rudert, “Induction of endostatin expression in
meniscal ﬁbrochondrocytes by co-culture with endothelial
cells,” Archives of Orthopaedic and Trauma Surgery, vol. 129,
no. 8, pp. 1137–1143, 2009.
[8] W. R. Krause, M. H. Pope, R. J. Johnson, and D. G. Wilder,
“Mechanical changes in the knee after meniscectomy,” Jour-
nal of Bone and Joint Surgery—Series A,v o l .5 8 ,n o .5 ,p p .
599–604, 1976.
[ 9 ]I .M .L e v y ,P .A .T o r z i l l i ,J .D .G o u l d ,a n dR .F .W a r r e n ,“ T h e
eﬀectoflateralmeniscectomyonmotionoftheknee,”Journal
of Bone and Joint Surgery—Series A, vol. 71, no. 3, pp. 401–
406, 1989.
[10] H. Roos, M. Laur´ e n ,T .A d a l b e r t h ,E .M .R o o s ,K .J o n s s o n ,
and L. S. Lohmander, “Knee osteoarthritis after menis-
cectomy: prevalence of radiographic changes after twenty-
one years, compared with matched controls,” Arthritis and
Rheumatism, vol. 41, no. 4, pp. 687–693, 1998.
[ 1 1 ]H .R o o s ,T .A d a l b e r t h ,L .D a h l b e r g ,a n dL .S .L o h m a n d e r ,
“Osteoarthritis of the knee after injury to the anterior
cruciateligamentormeniscus:theinﬂuenceoftimeandage,”
Osteoarthritis and Cartilage, vol. 3, no. 4, pp. 261–267, 1995.
[12] F. Forriol, U. G. Longo, D. Hern´ andez-Vaquero et al., “The
eﬀects of previous meniscus and anterior cruciate ligamentStem Cells International 5
injuries in patients with total knee arthroplasty,” Ortopedia
Traumatologia Rehabilitacja, vol. 12, no. 1, pp. 50–57, 2010.
[13] I.D.McDermottandA.A.Amis,“Theconsequencesofmen-
iscectomy,” Journal of Bone and Joint Surgery—Series B, vol.
88, no. 12, pp. 1549–1556, 2006.
[14] M. Englund, A. Guermazi, and L. S. Lohmander, “The
meniscus in knee osteoarthritis,” Rheumatic Disease Clinics
of North America, vol. 35, no. 3, pp. 579–590, 2009.
[15] D. H. Gershuni, M. J. Skyhar, L. A. Danzig, J. Camp, A.
R. Hargens, and W. H. Akeson, “Experimental models to
promote healing of tears in the avascular segment of canine
knee menisci,” Journal of Bone and Joint Surgery—Series A,
vol. 71, no. 9, pp. 1363–1370, 1989.
[16] K. Okuda, M. Ochi, N. Shu, and Y. Uchio, “Meniscal rasping
forrepairofmeniscaltearintheavascularzone,”Arthroscopy,
vol. 15, no. 3, pp. 281–286, 1999.
[17] Z. Zhang, K. Tu, Y. Xu, W. Zhang, Z. Liu, and S. Ou,
“Treatment of longitudinal injuries in avascular area of
meniscus in dogs by trephination,” Arthroscopy,v o l .4 ,n o .3 ,
pp. 151–159, 1988.
[18] Z. Zhang, J. A. Arnold, T. Willlams, B. McCann, and W.
D. Cannon, “Repairs by trephination and suturing of long-
itudinal injuries in the avascular area of the meniscus in
goats,” American Journal of Sports Medicine, vol. 23, no. 1, pp.
35–41, 1995.




[20] M. Ochi, Y. Uchio, K. Okuda, N. Shu, H. Yamaguchi, and
Y. Sakai, “Expression of cytokines after meniscal rasping to
promote meniscal healing,” Arthroscopy,v o l .1 7 ,n o .7 ,p p .
724–731, 2001.
[ 2 1 ]P .R .J .A m e s ,U .G .L o n g o ,V .D e n a r o ,a n dN .M a ﬀulli,
“Achilles tendon problems: not just an orthopaedic issue,”
Disability and Rehabilitation, vol. 30, no. 20–22, pp. 1646–
1650, 2008.
[22] M. H. Amlang, N. Maﬀuli, G. Longo, T. St¨ ubig, J. Imrecke,
and T. H¨ ufner, “Surgical treatment of Achilles tendon rup-
ture,” Unfallchirurg, vol. 113, no. 9, pp. 712–720, 2010.
[23] C. Becher, A. Driessen, T. Hess, U. G. Longo, N. Maﬀulli,
and H. Thermann, “Microfracture for chondral defects of
thetalus:maintenanceofearlyresultsatmidtermfollow-up,”
Knee Surgery, Sports Traumatology, Arthroscopy,v o l .1 8 ,n o .5 ,
pp. 656–663, 2010.
[ 2 4 ]L .C a p u a n o ,P .H a r d y ,U .G .L o n g o ,V .D e n a r o ,a n dN .
Maﬀulli, “No diﬀerence in clinical results between femoral
transﬁxation and bio-interference screw ﬁxation in ham-
string tendon ACL reconstruction. A preliminary study,”
Knee, vol. 15, no. 3, pp. 174–179, 2008.
[25] R. Castricini, U. G. Longo, M. De Benedetto et al., “Platelet-
rich plasma augmentation for arthroscopic rotator cuﬀ
repair: a randomized controlled trial,” American Journal of
Sports Medicine, vol. 39, no. 2, pp. 258–265, 2011.
[26] M. Chimutengwende-Gordon, W. S. Khan, J. Sidhu, U. G.
Longo, and N. Maruthainar, “Advanced trauma life support
radiographic trauma series: part 2—the chest radiograph,”
Journal of perioperative practice, vol. 20, no. 12, pp. 430–435,
2010.
[ 2 7 ]P .D eM o z z i ,U .G .L o n g o ,G .G a l a n t i ,a n dN .M a ﬀulli,
“Bicuspid aortic valve: a literature review and its impact on
sport activity,” British Medical Bulletin, vol. 85, no. 1, pp. 63–
85, 2008.
[28] V. Denaro, A. Di Martino, U. G. Longo et al., “Eﬀectiveness
of a mucolythic agent as a local adjuvant in revision lumbar
spine surgery,” European Spine Journal, vol. 17, no. 12, pp.
1752–1756, 2008.
[29] L. Denaro, U. G. Longo, R. Papalia, A. Di Martino, N.
Maﬀulli, and V. Denaro, “Eosinophilic granuloma of the
pediatric cervical spine,” Spine, vol. 33, no. 24, pp. E936–
E941, 2008.
[30] L. Denaro, U. G. Longo, and V. Denaro, “Vertebroplasty
and kyphoplasty: reasons for concern?” Orthopedic Clinics of
North America, vol. 40, no. 4, pp. 465–471, 2009.
[31] V. Denaro, L. Ruzzini, U. G. Longo et al., “Eﬀect of dihy-
drotestosterone on cultured human tenocytes from intact
supraspinatus tendon,” Knee Surgery, Sports Traumatology,
Arthroscopy, vol. 18, no. 7, pp. 971–976, 2010.
[32] V. Denaro, U. G. Longo, and L. Denaro, “Vertebroplasty
versus conservative treatment for vertebral fractures,” The
Lancet, vol. 376, no. 9758, p. 2071, 2010.
[33] V. Denaro, L. Ruzzini, S. A. Barnaba et al., “Eﬀect of pulsed
electromagnetic ﬁelds on human tenocyte cultures from
supraspinatus and quadriceps tendons,” American Journal of
Physical Medicine and Rehabili, vol. 90, no. 2, pp. 119–127,
2011.
[34] S. P. Arnoczky, R. F. Warren, and J. M. Spivak, “Meniscal
repair using an exogenous ﬁbrin clot. An experimental study
in dogs,” Journal of Bone and Joint Surgery—Series A, vol. 70,
no. 8, pp. 1209–1217, 1988.
[35] C. E. Henning, M. A. Lynch, K. M. Yearout, S. W. Vequist,
R. J. Stallbaumer, and K. A. Decker, “Arthroscopic meniscal
repair using an exogenous ﬁbrin clot,” Clinical Orthopaedics
and Related Research, no. 252, pp. 64–72, 1990.
[36] M. Ishimura, S. Tamai, and Y. Fujisawa, “Arthroscopic
meniscal repair with ﬁbrin glue,” Arthroscopy, vol. 7, no. 2,
pp. 177–181, 1991.
[37] M. F. van Trommel, P. T. Simonian, H. G. Potter, and T. L.
Wickiewicz, “Arthroscopic meniscal repair with ﬁbrin clot of
complete radial tears of the lateral meniscus in the avascular
zone,” Arthroscopy, vol. 14, no. 4, pp. 360–365, 1998.
[38] F. Forriol, U. G. Longo, J. Pueyo, N. Maﬀulli, and V.
Denaro, “Computed tomography-based study of age- and
sex-related variation in morphology of the femur,” Ortopedia
TraumatologiaRehabilitacja,vol.11,no.6,pp.542–548,2009.
[39] F. Forriol, U. G. Longo, C. Concejo, P. Ripalda, N. Maﬀulli,
and V. Denaro, “Platelet-rich plasma, rhOP-1 (rhBMP-7)
and frozen rib allograft for the reconstruction of bony
mandibular defects in sheep. A pilot experimental study,”
Injury, vol. 40, supplement 3, pp. S44–S49, 2009.
[ 4 0 ] F .F o r r i o l ,L .D e n a r o ,U .G .L o n g o ,H .T a i r a ,N .M a ﬀulli, and
V. Denaro, “Bone lengthening osteogenesis, a combination
of intramembranous and endochondral ossiﬁcation: an
experimental study in sheep,” Strategies in Trauma and Limb
Reconstruction, vol. 5, no. 2, pp. 71–78, 2010.
[41] F. Forriol, U. G. Longo, E. Alvarez et al., “Scanty inte-
gration of osteochondral allografts cryopreserved at low
temperatures with dimethyl sulfoxide,” Knee Surgery, Sports
Traumatology, Arthroscopy, vol. 19, no. 7, pp. 1184–1191,
2011.
[42] F. Franceschi, A. Marinozzi, R. Papalia, U. G. Longo, G.
Gualdi, and E. Denaro, “Intra- and juxta-articular osteoid
osteoma: a diagnostic challenge,” Archives of Orthopaedic and
Trauma Surgery, vol. 126, no. 10, pp. 660–667, 2006.
[43] F. Franceschi, U. G. Longo, L. Ruzzini, G. Rizzello, and V.
Denaro, “Arthroscopic management of calciﬁc tendinitis of6 Stem Cells International
thesubscapularistendon,”KneeSurgery,SportsTraumatology,
Arthroscopy, vol. 15, no. 12, pp. 1482–1485, 2007.
[44] F. Franceschi, U. G. Longo, L. Ruzzini et al., “Dislocation of
an enlarged fabella as uncommon cause of knee pain. A case
report,” Knee, vol. 14, no. 4, pp. 330–332, 2007.
[45] F. Franceschi, L. Ruzzini, U. G. Longo et al., “Equivalent
clinical results of arthroscopic single-row and double-row
suture anchor repair for rotator cuﬀ tears: a randomized
controlled trial,” American Journal of Sports Medicine, vol. 35,
no. 8, pp. 1254–1260, 2007.
[46] F. Franceschi, U. G. Longo, L. Ruzzini, and V. Denaro,
“Isolated tuberculosis of the patellar tendon,” Journal of Bone
and Joint Surgery—Series B, vol. 89, no. 11, pp. 1525–1526,
2007.
[47] F. Franceschi, G. U. Longo, L. Ruzzini, G. Rizzello, N.
Maﬀulli, and V. Denaro, “The Roman Bridge: a “double
pulley-suture bridges” technique for rotator cuﬀ repair,”
BMC Musculoskeletal Disorders, vol. 8, article 123, 2007.
[48] F. Franceschi, U. G. Longo, L. Ruzzini, R. Papalia, G. Rizzello,
and V. Denaro, “To detach the long head of the biceps tendon
after tenodesis or not: outcome analysis at the 4-year follow-
up of two diﬀerent techniques,” International Orthopaedics,
vol. 31, no. 4, pp. 537–545, 2007.
[49] F. Franceschi, U. G. Longo, L. Ruzzini, G. Rizzello, N.
Maﬀulli, and V. Denaro, “Arthroscopic salvage of failed
arthroscopic Bankart repair: a prospective study with a
minimum follow-up of 4 years,” American Journal of Sports
Medicine, vol. 36, no. 7, pp. 1330–1336, 2008.
[50] F. Franceschi, U. G. Longo, L. Ruzzini et al., “Circulating
substance P levels and shoulder joint contracture after
arthroscopic repair of the rotator cuﬀ,” British Journal of
Sports Medicine, vol. 42, no. 9, pp. 742–745, 2008.
[51] F. Franceschi, U. G. Longo, L. Ruzzini et al., “En-bloc
retrograde resection of an osteoid osteoma of the patella
using computed tomography under arthroscopic control,”
The Journal of Knee Surgery, vol. 21, no. 2, pp. 136–140, 2008.
[52] F. Franceschi, U. Giuseppe Longo, L. Ruzzini, G. Rizzello,
N. Maﬀulli, and V. Denaro, “No advantages in repairing a
type II superior labrum anterior and posterior (SLAP) lesion
when associated with rotator cuﬀ repair in patients over age
50: a randomized controlled trial,” American Journal of Sports
Medicine, vol. 36, no. 2, pp. 247–253, 2008.
[53] F.Franceschi,U.G.Longo,L.Ruzzini,R.Papalia,N.Maﬀulli,
and V. Denaro, “Quadriceps tendon-patellar bone autograft
for anterior cruciate ligament reconstruction: a technical
note,” Bulletin of the NYU Hospital for Joint Diseases, vol. 66,
no. 2, pp. 120–123, 2008.
[54] F. Franceschi, U. G. Longo, L. Ruzzini, A. Marinozzi, N.
Maﬀulli,andV.Denaro,“Simultaneousarthroscopicimplan-
tation of autologous chondrocytes and high tibial osteotomy
for tibial chondral defects in the varus knee,” Knee, vol. 15,
no. 4, pp. 309–313, 2008.
[55] F. Franceschi, U. G. Longo, L. Ruzzini, G. Rizzello, N.
Maﬀulli, and V. Denaro, “Soft tissue tenodesis of the long
head of the biceps tendon associated to the Roman Bridge
repair,” BMC Musculoskeletal Disorders, vol. 9, article 78,
2008.
[56] G. Garau, J. Rittweger, P. Mallarias, U. G. Longo, and N.
Maﬀulli, “Traumatic patellar tendinopathy,” Disability and
Rehabilitation, vol. 30, no. 20–22, pp. 1616–1620, 2008.
[57] A. Giombini, S. Dragoni, T. Averna, M. Ripani, U. G. Longo,
and N. Maﬀulli, “Osteoid osteoma mimicking overuse syn-
dromes in athletes,” Journal of Sports Medicine and Physical
Fitness, vol. 49, no. 2, pp. 167–170, 2009.
[58] J. Hashimoto, M. Kurosaka, S. Yoshiya, and K. Hirohata,
“Meniscal repair using ﬁbrin sealant and endothelial cell
growth factor. An experimental study in dogs,” American
Journal of Sports Medicine, vol. 20, no. 5, pp. 537–541, 1992.
[ 5 9 ]J .P o r t ,D .W .J a c k s o n ,T .Q .L e e ,a n dT .M .S i m o n ,
“Meniscal repair supplemented with exogenous ﬁbrin clot
a n da u t o g e n o u sc u l t u r e dm a r r o wc e l l si nt h eg o a tm o d e l , ”
American Journal of Sports Medicine, vol. 24, no. 4, pp. 547–
555, 1996.
[ 6 0 ]R .C .B r a y ,J .A .S m i t h ,M .K .E n g ,C .A .L e o n a r d ,C .A .
Sutherland,andP.T.Salo,“Vascularresponseofthemeniscus
to injury: eﬀects of immobilization,” J o u r n a lo fO r t h o p a e d i c
Research, vol. 19, no. 3, pp. 384–390, 2001.
[61] M. Ochi, Y. Mochizuki, M. Deie, and Y. Ikuta, “Augmented
meniscal healing with free synovial autografts: an organ
culture model,” Archives of Orthopaedic and Trauma Surgery,
vol. 115, no. 3-4, pp. 123–126, 1996.
[62] I. Mitani, S. Sumita, N. Takahashi, H. Ochiai, and M. Ishii,
“123I-MIBG myocardial imaging in hypertensive patients:
abnormality progresses with left ventricular hypertrophy,”
Annals of Nuclear Medicine, vol. 10, no. 3, pp. 315–321, 1996.
[63] K. Kobayashi, E. Fujimoto, M. Deie, Y. Sumen, Y. Ikuta, and
M. Ochi, “Regional diﬀerences in the healing potential of the
meniscus—anorganculturemodeltoeliminatetheinﬂuence
of microvasculature and the synovium,” Knee, vol. 11, no. 4,
pp. 271–278, 2004.
[64] P. C. M. Verdonk, R. G. Forsyth, J. Wang et al., “Characterisa-
tion of human knee meniscus cell phenotype,” Osteoarthritis
and Cartilage, vol. 13, no. 7, pp. 548–560, 2005.
[65] C. St¨ arke, S. Kopf, W. Petersen, and R. Becker, “Meniscal
repair,” Arthroscopy, vol. 25, no. 9, pp. 1033–1044, 2009.
[66] M. Ohishi and E. Schipani, “Bone marrow mesenchymal
stem cells,” Journal of Cellular Biochemistry, vol. 109, no. 2,
pp. 277–282, 2010.
[67] U. N¨ o t h ,A .M .O s y c z k a ,R .T u l i ,N .J .H i c k o k ,K .G .
Danielson, and R. S. Tuan, “Multilineage mesenchymal dif-
ferentiation potential of human trabecular bone-derived
cells,” Journal of Orthopaedic Research,v o l .2 0 ,n o .5 ,p p .
1060–1069, 2002.
[68] R. O. C. Oreﬀo, C. Cooper, C. Mason, and M. Clements,
“Mesenchymal stem cells lineage, plasticity, and skeletal
therapeutic potential,” Stem Cell Reviews,v o l .1 ,n o .2 ,p p .
169–178, 2005.
[69] J.L.Cook,“Thecurrentstatusoftreatmentforlargemeniscal
defects,” Clinical Orthopaedics and Related Research, no. 435,
pp. 88–95, 2005.
[70] J. Zellner, M. Mueller, A. Berner et al., “Role of mesenchymal
stem cells in tissue engineering of meniscus,” Journal of
Biomedical Materials Research—Part A,v o l .9 4 ,n o .4 ,p p .
1150–1161, 2010.
[71] M. Abdel-Hamid, M. R. Hussein, A. F. Ahmad, and E. M.
Elgezawi, “Enhancement of the repair of meniscal wounds in
the red-white zone (middle third) by the injection of bone
marrow cells in canine animal model,” International Journal
of Experimental Pathology, vol. 86, no. 2, pp. 117–123, 2005.
[72] Y. Izuta, M. Ochi, N. Adachi, M. Deie, T. Yamasaki, and
R. Shinomiya, “Meniscal repair using bone marrow-derived
mesenchymal stem cells: experimental study using green
ﬂuorescent protein transgenic rats,” Knee, vol. 12, no. 3, pp.
217–223, 2005.
[73] K. R. Stone, W. G. Rodkey, R. Webber, L. McKinney, and J. R.
Steadman, “Meniscal regeneration with copolymeric colla-
gen scaﬀolds. In vitro and in vivo studies evaluated clinically,Stem Cells International 7
histologically, and biochemically,” American Journal of Sports
Medicine, vol. 20, no. 2, pp. 104–111, 1992.
[74] A. F. Steinert, G. D. Palmer, R. Capito et al., “Genetically
enhanced engineering of meniscus tissue using ex vivo
delivery of transforming growth factor-β1c o m p l e m e n t a r y
deoxyribonucleic acid,” Tissue Engineering,v o l .1 3 ,n o .9 ,p p .
2227–2237, 2007.
[75] A. Q. Dutton, P. F. Choong, J. C. H. Goh, E. H. Lee, and J.
H. P. Hui, “Enhancement of meniscal repair in the avascular
zone using mesenchymal stem cells in a porcine model,”
Journal of Bone and Joint Surgery—Series B,v o l .9 2 ,n o .1 ,p p .
169–175, 2010.
[ 7 6 ]M .B .P a b b r u w e ,W .K a ﬁ e n a h ,J .F .T a r l t o n ,S .M i s t r y ,D .
J. Fox, and A. P. Hollander, “Repair of meniscal cartilage
white zone tears using a stem cell/collagen-scaﬀold implant,”
Biomaterials, vol. 31, no. 9, pp. 2583–2591, 2010.
[77] G.M.Peretti,T.J.Gill,J.W.Xu,M.A.Randolph,K.R.Morse,
and D. J. Zaleske, “Cell-based therapy for meniscal repair: a
large animal study,” American Journal of Sports Medicine, vol.
32, no. 1, pp. 146–158, 2004.
[78] C. Weinand, G. M. Peretti, S. B. Adams, M. A. Randolph,
E. Savvidis, and T. J. Gill, “Healing potential of transplanted
allogeneic chondrocytes of three diﬀerent sources in lesions
of the avascular zone of the meniscus: a pilot study,” Archives
of Orthopaedic and Trauma Surgery, vol. 126, no. 9, pp. 599–
605, 2006.
[79] N.S.TumiaandA.J.Johnstone,“Promotingtheproliferative
and synthetic activity of knee meniscal ﬁbrochondrocytes
using basic ﬁbroblast growth factor in vitro,” American
Journal of Sports Medicine, vol. 32, no. 4, pp. 915–920, 2004.
[80] J. L. Vander Schilden, J. L. York, and R. J. Webber, “Age-
dependent ﬁbrin clot invasion by human meniscal ﬁbro-
chondrocytes. A preliminary report,” Orthopaedic Review,
vol. 20, no. 12, pp. 1089–1097, 1991.
[81] K. Nakata, K. Shino, M. Hamada et al., “Human meniscus
cell:characterizationoftheprimarycultureandusefortissue
engineering,” Clinical Orthopaedics and Related Research,n o .
391, pp. S208–S218, 2001.
[82] T. Tanaka, K. Fujii, and Y. Kumagae, “Comparison of
biochemical characteristics of cultured ﬁbrochondrocytes
isolated from the inner and outer regions of human menis-
cus,” Knee Surgery, Sports Traumatology, Arthroscopy, vol. 7,
no. 3, pp. 75–80, 1999.
[83] W. S. Khan and U. G. Longo, “ACI and MACI procedures
forcartilagerepairutilisemesenchymalstemcellsratherthan
chondrocytes,” Medical Hypotheses, vol. 77, no. 2, p. 309,
2011.
[84] A. Khanna, N. Gougoulias, U. G. Longo, and N. Maﬀulli,
“Minimally invasive total knee arthroplasty: a systematic
review,” Orthopedic Clinics of North America,v o l .4 0 ,n o .4 ,
pp. 479–489, 2009.
[85] A. Khanna, M. Friel, N. Gougoulias, U. G. Longo, and N.
Maﬀulli, “Prevention of adhesions in surgery of the ﬂexor
tendons of the hand: what is the evidence?” British Medical
Bulletin, vol. 90, no. 1, pp. 85–109, 2009.
[ 8 6 ] K .K n o b l o c h ,L .S c h r e i b m u e l l e r ,U .G .L o n g o ,a n dP .M .V o g t ,
“Eccentric exercises for the management of tendinopathy of
the main body of the Achilles tendon with or without an
AirHeelTM Brace. A randomized controlled trial. B: eﬀects of
compliance,” DisabilityandRehabilitation,vol.30,no.20–22,
pp. 1692–1696, 2008.
[ 8 7 ] K .K n o b l o c h ,L .S c h r e i b m u e l l e r ,U .G .L o n g o ,a n dP .M .V o g t ,
“Eccentric exercises for the management of tendinopathy of
the main body of the Achilles tendon with or without the
AirHeelTM Brace. A randomized controlled trial. A: eﬀects on
painandmicrocirculation,”DisabilityandRehabilitation,vol.
30, no. 20–22, pp. 1685–1691, 2008.
[88] G.Lippi,U.G.Longo,andN.Maﬀulli,“Geneticsandsports,”
British Medical Bulletin, vol. 93, no. 1, pp. 27–47, 2010.
[89] G.Longo,P.Ripalda,V.Denaro,andF.Forriol,“Morphologic
comparison of cervical, thoracic, lumbar intervertebral discs
of cynomolgus monkey (Macaca fascicularis),” European
Spine Journal, vol. 15, no. 12, pp. 1845–1851, 2006.
[90] U. G. Longo, F. Franceschi, L. Ruzzini et al., “Light micro-
scopic histology of supraspinatus tendon ruptures,” Knee
Surgery, Sports Traumatology, Arthroscopy, vol. 15, no. 11, pp.
1390–1394, 2007.
[91] U. G. Longo, J. B. King, V. Denaro, and N. Maﬀulli, “Double-
bundle arthroscopic reconstruction of the anterior cruciate
ligament: does the evidence add up?” Journal of Bone and
Joint Surgery—Series B, vol. 90, no. 8, pp. 995–999, 2008.
[92] U. G. Longo, F. Franceschi, L. Ruzzini et al., “Histopathology
of the supraspinatus tendon in rotator cuﬀ tears,” American
Journal of Sports Medicine, vol. 36, no. 3, pp. 533–538, 2008.
[93] U. G. Longo, C. Ramamurthy, V. Denaro, and N. Maf-
fulli, “Minimally invasive stripping for chronic Achilles
tendinopathy,” Disability and Rehabilitation, vol. 30, no. 20–
22, pp. 1709–1713, 2008.
[94] S. P. Arnoczky, “Building a meniscus: biologic considera-
tions,” Clinical Orthopaedics and Related Research, no. 367,
pp. S244–S253, 1999.
[95] D. B. Fox, J. J. Warnock, A. M. Stoker, J. K. Luther, and
M. Cockrell, “Eﬀects of growth factors on equine synovial
ﬁbroblasts seeded on synthetic scaﬀolds for avascular menis-
cal tissueengineering,” Researchin VeterinaryScience,vol. 88,
no. 2, pp. 326–332, 2010.
[96] T. Vincent, M. Hermansson, M. Bolton, R. Wait, and J.
Saklatvala, “Basic FGF mediates an immediate response of
articular cartilage to mechanical injury,” Proceedings of the
National Academy of Sciences of the United States of America,
vol. 99, no. 12, pp. 8259–8264, 2002.
[97] A. Narita, M. Takahara, T. Ogino, S. Fukushima, Y. Kimura,
and Y. Tabata, “Eﬀect of gelatin hydrogel incorporating
ﬁbroblast growth factor 2 on human meniscal cells in an
organ culture model,” Knee, vol. 16, no. 4, pp. 285–289, 2009.
[98] I. Martin, A. Muraglia, G. Campanile, R. Cancedda, and
R. Quarto, “Fibroblast growth factor-2 supports ex vivo
expansion and maintenance of osteogenic precursors from
human bone marrow,” Endocrinology, vol. 138, no. 10, pp.
4456–4462, 1997.
[99] M. Cucchiarini, S. Schetting, E. F. Terwilliger, D. Kohn, and
H. Madry, “rAAV-mediated overexpression of FGF-2 pro-
motes cell proliferation, survival, and α-SMA expression in
human meniscal lesions,” Gene Therapy, vol. 16, no. 11, pp.
1363–1372, 2009.
[100] I. Izal, P. Ripalda, C. A. Acosta, and F. Forriol, “In vitro heal-
ing of avascular meniscal injuries with fresh and frozen plugs
treated with TGF-beta1 and IGF-1 in sheep,” International
Journal of Clinical and Experimental Pathology, vol. 1, pp.
426–434, 2008.
[101] S. Collier and P. Ghosh, “Eﬀects of transforming growth
factor beta on proteoglycan synthesis by cell and explant
culturesderivedfromthekneejointmeniscus,”Osteoarthritis
and Cartilage, vol. 3, no. 2, pp. 127–138, 1995.
[102] C. A. Pangborn and K. A. Athanasiou, “Eﬀects of growth
factors on meniscal ﬁbrochondrocytes,” Tissue Engineering,
vol. 11, no. 7-8, pp. 1141–1148, 2005.8 Stem Cells International
[103] D. J. Huey and K. A. Athanasiou, “Maturational growth of
self-assembled, functional menisci as a result of TGF-β1a n d
enzymatic chondroitinase-ABC stimulation,” Biomaterials,
vol. 32, pp. 2052–2058, 2011.
[104] E. Ozkaynak, P. N. J. Schnegelsberg, D. F. Jin et al.,
“Osteogenic protein-2. A new member of the transforming
growth factor-β superfamily expressed early in embryogene-
sis,” The Journal of Biological Chemistry, vol. 267, no. 35, pp.
25220–25227, 1992.
[105] J. M. Wozney and V. Rosen, “Bone morphogenetic protein
and bone morphogenetic protein gene family in bone
formation and repair,” Clinical Orthopaedics and Related
Research, no. 346, pp. 26–37, 1998.
[106] N. Fukui, Y. Zhu, W. J. Maloney, J. Clohisy, and L. J. Sandell,
“Stimulation of BMP-2 expression by pro-inﬂammatory
cytokines IL-1 and TNF-α in normal and osteoarthritic
chondrocytes,” Journal of Bone and Joint Surgery—Series A,
vol. 85, no. 3, pp. 59–66, 2003.
[107] N. Shintani and E. B. Hunziker, “Chondrogenic diﬀeren-
tiation of bovine synovium: bone morphogenetic proteins
2 and 7 and transforming growth factor β1 induce the
formation of diﬀerent types of cartilaginous tissue,” Arthritis
and Rheumatism, vol. 56, no. 6, pp. 1869–1879, 2007.
[108] H.J.Im,C.Pacione,S.Chubinskaya,A.J.vanWijnen,Y.Sun,
and R. F. Loeser, “Inhibitory eﬀects of insulin-like growth
factor-1 and osteogenic protein-1 on ﬁbronectin fragment-
and interleukin-1β-stimulated matrix metalloproteinase-13
expression in human chondrocytes,” The Journal of Biological
Chemistry, vol. 278, no. 28, pp. 25386–25394, 2003.
[109] P. Buma, N. N. Ramrattan, T. G. van Tienen, and R. P. H.
Veth, “Tissue engineering of the meniscus,” Biomaterials, vol.
25, no. 9, pp. 1523–1532, 2004.
[110] U. G. Longo, F. Olivia, V. Denaro, and N. Maﬀulli, “Oxygen
species and overuse tendinopathy in athletes,” Disability and
Rehabilitation, vol. 30, no. 20–22, pp. 1563–1571, 2008.
[111] U. G. Longo, F. Franceschi, M. Loppini, N. Maﬀulli, and V.
Denaro, “Rating systems for evaluation of the elbow,” British
Medical Bulletin, vol. 87, no. 1, pp. 131–161, 2008.
[112] U. G. Longo, G. Garau, V. Denaro, and N. Maﬀulli, “Surgical
management of tendinopathy of biceps femoris tendon in
athletes,” Disability and Rehabilitation, vol. 30, no. 20–22, pp.
1602–1607, 2008.
[113] U.G.Longo,M.Ronga,andN.Maﬀulli,“Achillestendinopa-
thy,” Sports Medicine and Arthroscopy Review, vol. 17, no. 2,
pp. 112–126, 2009.
[114] U. G. Longo, M. Ronga, and N. Maﬀulli, “Acute ruptures of
the achilles tendon,” Sports Medicine and Arthroscopy Review,
vol. 17, no. 2, pp. 127–138, 2009.
[115] U. G. Longo, F. Franceschi, L. Ruzzini et al., “Characteristics
at haematoxylin and eosin staining of ruptures of the long
head of the biceps tendon,” British Journal of Sports Medicine,
vol. 43, no. 8, pp. 603–607, 2009.
[116] U. G. Longo, F. Franceschi, L. Ruzzini, C. Rabitti, M. Nicola,
and V. Denaro, “Foreign-body giant-cell reaction at the
donor site after autologous osteochondral transplant for
cartilaginous lesion. A case report,” Journal of Bone and Joint
Surgery—Series A, vol. 91, no. 4, pp. 945–949, 2009.
[117] U. G. Longo, F. Franceschi, L. Ruzzini, F. Spiezia, N. Maﬀulli,
and V. Denaro, “Higher fasting plasma glucose levels within
the normoglycaemic range and rotator cuﬀ tears,” British
Journal of Sports Medicine, vol. 43, no. 4, pp. 284–287, 2009.
[118] A. S. Kashyap, K. P. Anand, and S. Kashyap, “Minimally
invasive total knee arthroplasty,” The New England Journal of
Medicine, vol. 361, no. 6, pp. 633–634, 2009.
[119] U. G. Longo, J. Rittweger, G. Garau et al., “No inﬂuence of
age, gender, weight, height, and impact proﬁle in achilles
tendinopathy in masters track and ﬁeld athletes,” American
Journal of Sports Medicine, vol. 37, no. 7, pp. 1400–1405,
2009.
[120] U.G.Longo,N.Maﬀulli,andV.Denaro,“Rivaroxabanversus
enoxaparin after total knee arthroplasty,” The Lancet, vol.
374, no. 9691, pp. 681–682, 2009.
[121] U.G.LongoandV.Denaro,“Spinalaugmentation:whathave
we learnt?” The Lancet, vol. 373, no. 9679, p. 1947, 2009.
[122] U. G. Longo, N. Papapietro, N. Maﬀulli, and V. Denaro,
“Thoracoscopy for minimally invasive thoracic spine sur-
gery,” Orthopedic Clinics of North America,v o l .4 0 ,n o .4 ,p p .
459–464, 2009.
[123] T. Pufe, W. J. Petersen, N. Miosge et al., “Endostatin/collagen
XVIII—an inhibitor of angiogenesis—is expressed in carti-
lage and ﬁbrocartilage,” Matrix Biology,v o l .2 3 ,n o .5 ,p p .
267–276, 2004.
[124] W. Petersen, T. Pufe, C. St¨ arke et al., “Locally applied angi-
ogenic factors—a new therapeutic tool for meniscal repair,”
Annals of Anatomy, vol. 187, no. 5-6, pp. 509–519, 2005.
[125] G. R. Grotendorst, G. R. Martin, and D. Pencev, “Stimulation
of granulation tissue formation by platelet-derived growth
factor in normal and diabetic rats,” The Journal of Clinical
Investigation, vol. 76, no. 6, pp. 2323–2329, 1985.
[126] K. Kirchberg, T. S. Lange, E. C. Klein et al., “Induction of
β1integrinsynthesisbyrecombinantplatelet-derivedgrowth
factor (PDGF-AB) correlates with an enhanced migratory
responseofhumandermalﬁbroblaststovariousextracellular
matrix proteins,” Experimental Cell Research, vol. 220, no. 1,
pp. 29–35, 1995.
[127] K. P. Spindler, C. E. Mayes, R. R. Miller, A. K. Imro, and J.
M. Davidson, “Regional mitogenic response of the meniscus
to platelet-derived growth factor (PDGF-AB),” Journal of
Orthopaedic Research, vol. 13, no. 2, pp. 201–207, 1995.
[128] N. S. Tumia and A. J. Johnstone, “Platelet derived growth
factor-ABenhanceskneemeniscalcellactivityinvitro,”Knee,
vol. 16, no. 1, pp. 73–76, 2009.
[129] A. L. McNulty, B. T. Estes, R. E. Wilusz, J. B. Weinberg, and
F. Guilak, “Dynamic loading enhances integrative meniscal
repair in the presence of interleukin-1,” Osteoarthritis and
Cartilage, vol. 18, no. 6, pp. 830–838, 2010.
[130] A. L. McNulty, F. T. Moutos, J. B. Weinberg, and F. Guilak,
“Enhancedintegrativerepairoftheporcinemeniscusinvitro
by inhibition of interleukin-1 or tumor necrosis factor α,”
Arthritis and Rheumatism, vol. 56, no. 9, pp. 3033–3043,
2007.
[131] U.G.Longo,V.Fazio,M.L.Poetaetal.,“Bilateralconsecutive
rupture of the quadriceps tendon in a man with BstUI
polymorphism of the COL5A1 gene,” Knee Surgery, Sports
Traumatology, Arthroscopy, vol. 18, no. 4, pp. 514–518, 2010.
[132] U. G. Longo, F. Forriol, N. Maﬀulli, and V. Denaro, “Eval-
uation of histological scoring systems for tissue-engineered,
repaired and osteoarthritic cartilage,” Osteoarthritis and
Cartilage, vol. 18, no. 7, p. 1001, 2010.
[133] U. G. Longo, E. Franceschetti, N. Maﬀulli, and V. Denaro,
“Hip arthroscopy: state of the art,” British Medical Bulletin,
vol. 96, no. 1, pp. 131–157, 2010.
[134] U. G. Longo, M. Loppini, L. Denaro, N. Maﬀulli, and V.
Denaro, “Rating scales for low back pain,” British Medical
Bulletin, vol. 94, no. 1, pp. 81–144, 2010.
[135] U. G. Longo, A. Lamberti, N. Maﬀulli, and V. Denaro,
“Tendon augmentation grafts: a systematic review,” British
Medical Bulletin, vol. 94, no. 1, pp. 165–188, 2010.Stem Cells International 9
[136] U. G. Longo, F. Franceschi, F. Spiezia, F. Forriol, N. Maﬀulli,
and V. Denaro, “Triglycerides and total serum cholesterol in
rotator cuﬀ tears: do they matter?” British Journal of Sports
Medicine, vol. 44, no. 13, pp. 948–951, 2010.
[137] U.G.Longo,L.Denaro,S.Campi,N.Maﬀulli,andV.Denaro,
“Upper cervical spine injuries: indications and limits of the
conservative management in Halo vest. A systematic review
of eﬃcacy and safety,” Injury, vol. 41, no. 11, pp. 1127–1135,
2010.
[138] U. G. Longo, S. Buchmann, E. Franceschetti, N. Maﬀulli,
and V. Denaro, “A systematic review of single-bundle versus
double-bundle anterior cruciate ligament reconstruction,”
British Medical Bulletin. In press.
[139] U. G. Longo, F. Forriol, S. Campi, N. Maﬀulli, and V. Denaro,
“Animal models for translational research on shoulder
pathologies: from bench to bedside,” Sports Medicine and
Arthroscopy Review, vol. 19, no. 3, pp. 184–193, 2011.
[140] U. G. Longo, S. Buchmann, A. Berton, N. Maﬀulli, and V.
Denaro, “Arthroscopic knots and strength sutures for rotator
cuﬀ repair,” Sports Medicine and Arthroscopy Review, vol. 19,
no. 3, pp. 251–265, 2011.
[141] U. G. Longo, A. Berton, P. M. Ahrens, N. Maﬀulli, and
V. Denaro, “Clinical tests for the diagnosis of rotator cuﬀ
disease,” Sports Medicine and Arthroscopy Review, vol. 19, no.
3, pp. 266–278, 2011.
[142] U. G. Longo, S. Banerjee, J. Barber et al., “Conservative
management versus open reduction and internal ﬁxation
for mid-shaft clavicle fractures in adults—the Clavicle Trial:
study protocol for a multicentre randomized controlled
trial,” Trials, vol. 12, article 57, 2011.
[143] U. G. Longo, A. Berton, W. S. Khan, N. Maﬀulli, and
V. Denaro, “Histopathology of rotator cuﬀ tears,” Sports
Medicine and Arthroscopy Review, vol. 19, no. 3, pp. 227–236,
2011.
[144] U.G.Longo,J.Rittweger,G.Garauetal.,“Patellartendinopa-
thy in master track and ﬁeld athletes: inﬂuence of impact
proﬁle, weight, height, age and gender,” Knee Surgery, Sports
Traumatology, Arthroscopy, vol. 19, no. 3, pp. 508–512, 2011.
[145] U. G. Longo, S. Vasta, N. Maﬀulli, and V. Denaro, “Scoring
systems for the functional assessment of patients with rotator
cuﬀ pathology,” Sports Medicine and Arthroscopy Review, vol.
19, no. 3, pp. 310–320, 2011.
[146] U. G. Longo, L. Denaro, F. Spiezia, F. Forriol, N. Maﬀulli,and
V. Denaro, “Symptomatic disc herniation and serum lipid
levels,” European Spine Journal, vol. 20, no. 10, pp. 1658–
1662, 2011.
[147] U. G. Longo, F. Franceschi, F. Spiezia, A. Marinozzi, N.
Maﬀulli, and V. Denaro, “The low-proﬁle Roman bridge
technique for knotless double-row repair of the rotator cuﬀ,”
Archives of Orthopaedic and Trauma Surgery, vol. 131, no. 3,
pp. 357–361, 2011.
[148] U.G.Longo,A.Lamberti,N.Maﬀulli,andV.Denaro,“Tissue
engineered biological augmentation for tendon healing: a
systematic review,” British Medical Bulletin,v o l .9 8 ,n o .1 ,p p .
31–59, 2011.
[149] U.G.Longo,A.Marinozzi,L.Cazzato,C.Rabitti,N.Maﬀulli,
and V. Denaro, “Tuberculosis of the shoulder,” Journal of
Shoulder and Elbow Surgery, vol. 20, no. 4, pp. e19–e21, 2011.
[150] U. G. Longo, P. E. Huijsmans, N. Maﬀulli, V. Denaro, and
J. F. De Beer, “Video analysis of the mechanisms of shoulder
dislocationinfoureliterugbyplayers,”JournalofOrthopaedic
Science, vol. 16, no. 4, pp. 389–397, 2011.
[151] D. Delos and S. A. Rodeo, “Enhancing meniscal repair
through biology: platelet-rich plasma as an alternative strat-
egy,”InstructionalCourseLectures,vol.60,pp.453–460, 2011.
[152] U. G. Longo, F. Franceschi, A. Berton, N. Maﬀulli, and
V. Denaro, “Arthroscopic transosseous rotator cuﬀ repair,”
Medicine and Sport Science, vol. 57, pp. 142–152, 2012.
[153] U. G. Longo, A. Berton, N. Papapietro, N. Maﬀulli, and
V. Denaro, “Biomechanics of the rotator cuﬀ: european
perspective,” Medicine and Sport Science, vol. 57, pp. 10–17,
2012.
[154] U. G. Longo, F. Franceschi, A. Berton, N. Maﬀulli, and V.
Denaro, “Conservative treatment and rotator cuﬀ tear pro-
gression,” Medicine and Sport Science, vol. 57, pp. 90–99,
2012.
[155] U. G. Longo, A. Berton, N. Papapietro, N. Maﬀulli, and V.
Denaro, “Epidemiology, genetics and biological factors of
rotator cuﬀ tears,” Medicine and Sport Science, vol. 57, pp. 1–
9, 2012.
[156] U. G. Longo, A. Berton, A. Marinozzi, N. Maﬀulli, and V.
Denaro, “Subscapularis tears,” Medicine and Sport Science,
vol. 57, pp. 114–121, 2012.
[157] U. G. Longo, A. Lamberti, G. Rizzello, N. Maﬀulli, and
V. Denaro, “Synthetic augmentation in massive rotator cuﬀ
tears,” Medicine and Sport Science, vol. 57, pp. 168–177, 2012.
[158] N. Maﬀulli, A. Ajis, U. G. Longo, and V. Denaro, “Chronic
rupture of tendo achillis,” Foot and Ankle Clinics, vol. 12, no.
4, pp. 583–596, 2007.
[159] N. Maﬀulli and U. G. Longo, “Conservative management
for tendinopathy: is there enough scientiﬁc evidence?”
Rheumatology, vol. 47, no. 4, pp. 390–391, 2008.
[160] N. Maﬀu l l i ,G .W a l l e y ,M .S a y a n a ,U .G .L o n g o ,a n dV .
Denaro, “Eccentric calf muscle training in athletic patients
with Achilles tendinopathy,” Disability and Rehabilitation,
vol. 30, no. 20–22, pp. 1677–1684, 2008.
[161] N. Maﬀulli and U. G. Longo, “How do eccentric exercises
work in tendinopathy?” Rheumatology, vol. 47, no. 10, pp.
1444–1445, 2008.
[162] K.Ishida,R.Kuroda,M.Miwaetal.,“Theregenerativeeﬀects
of platelet-rich plasma on meniscal cells in vitro and its in
vivo application with biodegradable gelatin hydrogel,” Tissue
Engineering, vol. 13, no. 5, pp. 1103–1112, 2007.
[163] N. Maﬀu l l i ,U .G .L o n g o ,N .G o u g o u l i a s ,a n dV .D e n a r o ,
“Ipsilateral free semitendinosus tendon graft transfer for
reconstruction of chronic tears of the Achilles tendon,” BMC
Musculoskeletal Disorders, vol. 9, article 100, 2008.
[164] N. Maﬀu l l i ,U .G .L o n g o ,V .T e s t a ,F .O l i v a ,G .C a p a s s o ,
and V. Denaro, “Italian translation of the VISA-A score
for tendinopathy of the main body of the Achilles tendon,”
Disability and Rehabilitation, vol. 30, no. 20–22, pp. 1635–
1639, 2008.
[165] N. Maﬀu l l i ,U .G .L o n g o ,F .F r a n c e s c h i ,C .R a b i t t i ,a n dV .
Denaro, “Movin and bonar scores assess the same character-
istics of tendon histology,” Clinical Orthopaedics and Related
Research, vol. 466, no. 7, pp. 1605–1611, 2008.
[166] N. Maﬀulli, V. Testa, G. Capasso et al., “Surgery for chronic
Achilles tendinopathy produces worse results in women,”
Disability and Rehabilitation, vol. 30, no. 20–22, pp. 1714–
1720, 2008.
[167] N. Maﬀu l l i ,U .G .L o n g o ,V .T e s t a ,F .O l i v a ,G .C a p a s s o ,a n d
V. Denaro, “VISA-P score for patellar tendinopathy in males:
adaptation to Italian,” Disability and Rehabilitation, vol. 30,
no. 20–22, pp. 1621–1624, 2008.10 Stem Cells International
[168] N. Maﬀulli, U. G. Longo, and V. Denaro, “Anterior cruciate
ligamenttear,”TheNewEnglandJournalofMedicine,vol.360,
no. 14, article 1463, 2009.
[169] N.Maﬀulli,U .G.Longo ,F .Oliva,V .Denaro ,andC.Coppola,
“Bosch osteotomy and scarf osteotomy for hallux valgus
correction,” Orthopedic Clinics of North America, vol. 40, no.
4, pp. 515–524, 2009.
[170] N. Maﬀulli, U. G. Longo, and V. Denaro, “Complications
after surgery or nonoperative treatment for acute achilles
tendon rpture,” ClinicalJournalofSportMedicine,vol. 19,no.
5, pp. 441–442, 2009.
[171] N.Maﬀulli,U.G.Longo,andV.Denaro,“Lettertotheeditor:
minimally invasive paratenon release for non-insertional
Achilles tendinopathy,” Foot & Ankle International, vol. 30,
pp. 1027–1028, 2009.
[172] N. Maﬀu l l i ,U .G .L o n g o ,F .O l i v a ,M .R o n g a ,a n dV .
Denaro, “Minimally invasive surgery of the achilles tendon,”
Orthopedic Clinics of North America, vol. 40, no. 4, pp. 491–
498, 2009.
[173] N. Maﬀu l l i ,U .G .L o n g o ,T .H¨ ufner, and V. Denaro, “Surgical
treatment for pain syndromes of the Achilles tendon,”
Unfallchirurg, vol. 113, no. 9, pp. 721–725, 2010.
[174] N. Maﬀulli, F. Franceschi, U. G. Longo, L. Ruzzini, and V.
Denaro,“Clinicalevidenceforsutureanchorrepairofrotator
cuﬀ tears does add up: some just do not want to see it,”
Arthroscopy, vol. 26, no. 12, pp. 1568–1569, 2010.
[175] N. Maﬀulli, U. G. Longo, M. Loppini, and V. Denaro, “Cur-
rent treatment options for tendinopathy,” Expert Opinion on
Pharmacotherapy, vol. 11, no. 13, pp. 2177–2186, 2010.
[176] N. Maﬀu l l i ,U .G .L o n g o ,M .R o n g a ,A .K h a n n a ,a n d
V. Denaro, “Favorable outcome of percutaneous repair of
achilles tendon ruptures in the elderly,” Clinical Orthopaedics
and Related Research, vol. 468, no. 4, pp. 1039–1046, 2010.
[177] N. Maﬀu l l i ,U .G .L o n g o ,F .S p i e z i a ,a n dV .D e n a r o ,“ F r e e
hamstrings tendon transfer and interference screw ﬁxation
for less invasive reconstruction of chronic avulsions of
the Achilles tendon,” Knee Surgery, Sports Traumatology,
Arthroscopy, vol. 18, no. 2, pp. 269–273, 2010.
[178] N. Maﬀulli, F. Spiezia, U. G. Longo, and V. Denaro, “Less-
invasive reconstruction of chronic achilles tendon ruptures
using a peroneus brevis tendon transfer,” American Journal of
Sports Medicine, vol. 38, no. 11, pp. 2304–2312, 2010.
[179] J. R. Ritchie, M. D. Miller, R. T. Bents, and D. K. Smith,
“Meniscel repair in the goat model: the use of healing
adjuncts on central tears and the role of magnetic resonance
arthrography in repair evaluation,” American Journal of
Sports Medicine, vol. 26, no. 2, pp. 278–284, 1998.
[180] N. Maﬀulli, U. G. Longo, N. Gougoulias, M. Loppini, and
V. Denaro, “Long-term health outcomes of youth sports
injuries,” British Journal of Sports Medicine,v o l .4 4 ,n o .1 ,p p .
21–25, 2010.
[181] N. Maﬀu l l i ,U .G .L o n g o ,a n dV .D e n a r o ,“ N o v e la p p r o a c h e s
for the management of tendinopathy,” Journal of Bone and
Joint Surgery—Series A, vol. 92, no. 15, pp. 2604–2613, 2010.
[182] N. Maﬀu l l i ,U .G .L o n g o ,F .S p i e z i a ,a n dV .D e n a r o ,
“Sports injuries in young athletes: long-term outcome and
prevention strategies,” Physician and Sportsmedicine, vol. 38,
no. 2, pp. 29–34, 2010.
[183] N. Maﬀu l l i ,U .G .L o n g o ,G .D .M a ﬀulli, A. Khanna, and
V. Denaro, “Achilles tendon ruptures in diabetic patients,”
Archives of Orthopaedic and Trauma Surgery, vol. 131, no. 1,
pp. 33–38, 2011.
[184] N. Maﬀu l l i ,U .G .L o n g o ,G .D .M a ﬀulli, A. Khanna, and V.
Denaro, “Achilles tendon ruptures in elite athletes,” Foot and
Ankle International, vol. 32, no. 1, pp. 9–15, 2011.
[185] N. Maﬀu l l i ,U .G .L o n g o ,F .S p i e z i a ,a n dV .D e n a r o ,
“Aetiology and prevention of injuries in elite young athletes,”
Medicine and Sport Science, vol. 56, pp. 187–200, 2010.
[186] N. Maﬀulli, U. G. Longo, A. Berton, M. Loppini, and V.
Denaro,“Biologicalfactorsinthepathogenesisofrotatorcuﬀ
tears,” Sports Medicine and Arthroscopy Review, vol. 19, no. 3,
pp. 194–201, 2011.
[187] N. Maﬀulli, U. G. Longo, A. Marinozzi, and V. Denaro,
“Hallux valgus: eﬀectiveness and safety of minimally invasive
surgery.Asystematicreview,”BritishMedicalBulletin,vol.97,
no. 1, pp. 149–167, 2011.
[188] N. Maﬀu l l i ,U .G .L o n g o ,G .D .M a ﬀulli, C. Rabitti, A.
Khanna, and V. Denaro, “Marked pathological changes prox-
imal and distal to the site of rupture in acute Achilles tendon
ruptures,” Knee Surgery, Sports Traumatology, Arthroscopy,
vol. 19, no. 4, pp. 680–687, 2011.
[189] N. Maﬀulli, U. G. Longo, N. Gougoulias, D. Caine, and
V. Denaro, “Sport injuries: a review of outcomes,” British
Medical Bulletin, vol. 97, no. 1, pp. 47–80, 2011.
[190] N. Malliaropoulos, M. Ntessalen, E. Papacostas, U. G. Longo,
and N. Maﬀulli, “Reinjury after acute Lateral ankle sprains
in elite track and ﬁeld athletes,” American Journal of Sports
Medicine, vol. 37, no. 9, pp. 1755–1761, 2009.
[191] A. Marinozzi, U. G. Longo, L. Cazzato, N. Martinelli, N.
Maﬀulli, and V. Denaro, “Bilateral tibial hallux sesamoid
agenesis and ﬁbular hallux sesamoid hypoplasia in a patient
withbilateralhalluxvalgus,”JournaloftheAmericanPodiatric
Medical Association, vol. 101, no. 5, pp. 452–455, 2011.
[192] N. Martinelli, U. G. Longo, A. Marinozzi, E. Franceschetti,
V. Costa, and V. Denaro, “Cross-cultural adaptation and
validation with reliability, validity, and responsiveness of the
Italian version of the Oxford Hip Score in patients with hip
osteoarthritis,” Quality of Life Research, vol. 20, pp. 923–929,
2011.
[193] P. Martinez de Albornoz, A. Khanna, U. G. Longo, F. Forriol,
and N. Maﬀulli, “The evidence of low-intensity pulsed
ultrasound for in vitro, animal and human fracture healing,”
British Medical Bulletin. In press.
[194] M. Nicol` o, R. Paolo, C. Francesco, M. Andrea, U. G. Longo,
and D. Vincenzo, “Hemiarthroplasty in a patient aﬀected by
osteonecrosis of the ﬁrst metatarsal head following chevron
osteotomy: a case report,” Foot, vol. 20, no. 1, pp. 32–34,
2010.
[195] F. Oliva, U. G. Longo, and N. Maﬀulli, “Minimally invasive
hallux valgus correction,” Orthopedic Clinics of North Amer-
ica, vol. 40, no. 4, pp. 525–530, 2009.
[196] F. Oliva, M. Ronga, U. G. Longo, V. Testa, G. Capasso, and N.
Maﬀulli, “The 3-in-1 procedure for recurrent dislocation of
the patella in skeletally immature children and adolescents,”
American Journal of Sports Medicine, vol. 37, no. 9, pp. 1814–
1820, 2009.
[197] G. Rizzello, F. Franceschi, U. G. Longo et al., “Arthroscopic
management of calciﬁc tendinopathy of the shoulder: do we
need to remove all the deposit?” Bulletin of the NYU Hospital
for Joint Diseases, vol. 67, no. 4, pp. 330–333, 2009.
[198] G. Rizzello, U. G. Longo, F. Franceschi et al., “Compression
neuropathy of the motor ﬁbers of the median nerve at wrist
level,” Journal of the Chinese Medical Association, vol. 72, no.
5, pp. 268–270, 2009.Stem Cells International 11
[199] G. Rizzello, U. G. Longo, N. Maﬀulli, and V. Denaro, “Arth-
roscopic removal of an intraarticular osteoid osteoma of the
distal tibia,” Journal of Foot and Ankle Surgery,v o l .4 9 ,n o .4 ,
pp. 398.e17–398.e21, 2010.
[200] M. Ronga, F. Oliva, U. G. Longo, V. Testa, G. Capasso,
and N. Maﬀulli, “Isolated medial patellofemoral ligament
reconstruction for recurrent patellar dislocation,” American
Journal of Sports Medicine, vol. 37, no. 9, pp. 1735–1742,
2009.
[201] M. Ronga, C. Shanmugam, U. G. Longo, F. Oliva, and N.
Maﬀulli, “Minimally invasive osteosynthesis of distal tibial
fractures using locking plates,” Orthopedic Clinics of North
America, vol. 40, no. 4, pp. 499–504, 2009.
[202] M. Ronga, U. G. Longo, and N. Maﬀulli, “Minimally invasive
locked plating of distal tibia fractures is safe and eﬀective,”
Clinical Orthopaedics and Related Research, vol. 468, no. 4,
pp. 975–982, 2010.
[203] H. Thermann, I. Gavriilidis, U. G. Longo, and N. Maﬀulli,
“Total ankle arthroplasty and tibialis posterior tendon trans-
ferforankleosteoarthritisanddropfootdeformity,”Foot and
Ankle Surgery, 2009.